Drug Discovery

Bio21 'Big Picture': Addressing Chronic Pain: A Major Health Problem in Australia and Globally - 3pm, 4 November

Monday, 4 November, 2019 - 15:00 to 16:00

Neuropathic pain is a large unmet medical need. Em Prof Smith tells about how a successful trial may see her work enter the clinic.

Media Release: Researchers discover why patients develop resistance to commonly-used cancer drug

Michael Parker and Craig Morton, St Vincent’s Institute of Medical Research (SVI) in Melbourne Australia, and Bio21 Institute are part of an international team of collaborators that has made a discovery that may lead to more effective treatment and less side effects for a number of cancers including neuroblastoma, a cancer that occurs most commonly in infants and children under 5 years of age.

Media Release: New hope in global race to beat malaria parasite’s deadly new resistance

Scientists have made a major breakthrough in the global search for a new drug to beat the malaria parasite’s growing resistance to first-defence treatments.

Bio21 researcher makes advances towards an antibody treatment for Alzheimer’s

Renowned scientist and Bio21 Institute researcher Professor Michael Parker was recently published in Scientific Reports for his research into antibody treatments for Alzheimer’s Disease.

Subscribe to RSS - Drug Discovery